These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 5416979)

  • 1. Metabolism of D- vs L-Dopa.
    Arras MJ
    N Engl J Med; 1970 Apr; 282(14):813. PubMed ID: 5416979
    [No Abstract]   [Full Text] [Related]  

  • 2. Contributions of host and intestinal microflora in the metabolism of L-dopa by the rat.
    Goldin BR; Peppercorn MA; Goldman P
    J Pharmacol Exp Ther; 1973 Jul; 186(1):160-6. PubMed ID: 4723308
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of D- vs L-dopa.
    Sandler M; Karoum F; Ruthven CR
    N Engl J Med; 1970 Apr; 282(14):813. PubMed ID: 5416980
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary metabolites from rats given L-DOPA.
    Borud O; Midtvedt T; Gjessing LR
    Acta Pharmacol Toxicol (Copenh); 1972; 31(5):540-9. PubMed ID: 4678834
    [No Abstract]   [Full Text] [Related]  

  • 5. Polyamide thin-layer chromatographic separation of DOPA metabolites and related compounds.
    Harrison SD; Chiu P; Maickel RP
    J Chromatogr; 1973 Oct; 85(1):151-3. PubMed ID: 4754395
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of dopa in Parkinsonism.
    Sandler M; Karoum F; Ruthven CR
    N Engl J Med; 1969 Dec; 281(25):1429. PubMed ID: 5355467
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism of 3,4-dihydroxyphenylalanine (L-dopa) in human subjects.
    Goodall M; Alton H
    Biochem Pharmacol; 1972 Sep; 21(17):2401-8. PubMed ID: 4647074
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical, electroencephalographic and biochemical aspects of the 1-dopa effect].
    Bente D; Stoerger R; Tautz NA
    Arzneimittelforschung; 1966 Feb; 16(2):265-7. PubMed ID: 6013814
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic fate of l-[14C] DOPA in cerebrospinal fluid and blood plasma of humans.
    Pletscher A; Bartholini G; Tissot R
    Brain Res; 1967 Feb; 4(1):106-9. PubMed ID: 6029941
    [No Abstract]   [Full Text] [Related]  

  • 10. m-Hydroxyphenylacetic acid formation from L-dopa in man: suppression by neomycin.
    Sandler M; Karoum F; Ruthven CR; Calne DB
    Science; 1969 Dec; 166(3911):1417-8. PubMed ID: 5350345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excretion of dopa metabolites.
    Kott E; Bornstein B; Eichhorn F
    N Engl J Med; 1971 Feb; 284(7):395. PubMed ID: 5539935
    [No Abstract]   [Full Text] [Related]  

  • 12. [Purity criteria of L-Dopa (L-dihydroxyphenylalanine)].
    Jouin J; Saias E
    Ann Pharm Fr; 1972 Feb; 30(2):139-44. PubMed ID: 5051261
    [No Abstract]   [Full Text] [Related]  

  • 13. Simultaneous measurement of DOPA and its primary metabolites in physiological fluids.
    Hare TA; Beasley BL; DeSimone SM; Vogel WH
    Biochem Med; 1974 Dec; 11(4):305-11. PubMed ID: 4429548
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study on metabolism of alpha, alpha-diethyl-3,4-methylenedioxyphenylacetamide (Hoe 264) in guinea pigs].
    Volz M
    Arzneimittelforschung; 1973 Aug; 23(8):1024-7. PubMed ID: 4801019
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolism of dihydroxyphenylalanine in human subjects.
    Smith P
    Nature; 1967 Feb; 213(5078):802-3. PubMed ID: 6031806
    [No Abstract]   [Full Text] [Related]  

  • 16. D-dopa is unidirectionally converted to L-dopa by D-amino acid oxidase, followed by dopa transaminase.
    Wu M; Zhou XJ; Konno R; Wang YX
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1042-6. PubMed ID: 17042912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) during L-dopa therapy of Parkinson's disease.
    van Woert MH; Bowers MB
    Neurology; 1970 Apr; 20(4):377. PubMed ID: 5534981
    [No Abstract]   [Full Text] [Related]  

  • 18. [Trials for a simple, enzymatic purity test of L-dopa].
    Sonanimi D
    Pharm Acta Helv; 1972 Oct; 47(10):588-93. PubMed ID: 4404894
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the possibility of detection of homogentisic acid in the urine of alkaptonuric patients by thin layer chromatography].
    Rondini G; Zaverio S
    Minerva Pediatr; 1968 May; 20(19):1022. PubMed ID: 5740609
    [No Abstract]   [Full Text] [Related]  

  • 20. The fate of C14-dihydroxyphenylalanine (C14-dopa) in the whole mouse.
    Wurtman RJ; Chou C; Rose C
    J Pharmacol Exp Ther; 1970 Sep; 174(3):351-6. PubMed ID: 5456168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.